- Home
- / Aurion Biotech
Aurion Biotech
Total Funding
$120 M
Aurion Biotech Summary
Company Summary
- Overview
- Aurion Biotech is a clinical stage biotech company that develops a platform of therapies to cure blindness. It treats corneal endothelial disease and validates cell therapies for corneal care.
- Type
- Private
- Status
- Active
- Founded
- 2021
- HQ
- Seattle, WA, US | view all locations
- Website
- https://aurionbiotech.com/
- Cybersecurity rating
Table of Contents
Key People
David Rostov, Chief Financial Officer
Arnaud Lacoste, Chief Scientific Officer
LocationsView all
1 location detected
Seattle, WA HQ
United States